Specialized NGS Services myGenomics offers custom target sequencing on the Illumina platform, catering to clients needing tailored genetic analysis solutions. This specialization presents opportunities to partner with research institutions and biotech companies seeking high-quality, customizable NGS services.

Experienced Scientific Team With all Ph.D. scientists averaging over 15 years of experience, myGenomics emphasizes expertise and quality. This positions the company as a reliable provider for clients prioritizing technical excellence, especially those requiring complex genetic assays.

Fast, Onshore Turnaround All services are performed domestically in the USA, ensuring rapid turnaround times and direct technical support. This benefits customers looking for quick results and localized service to support time-sensitive research or clinical projects.

Growth Potential in Research With a revenue range of 1 to 10 million dollars and a lean team of 2-10 employees, there are opportunities to expand sales by targeting emerging research institutions or biotech startups seeking reliable NGS partners for early-stage projects.

Market Positioning Opportunities Compared to larger competitors like 23andMe or Invitae, myGenomics’s focused niche and personalized service model can be leveraged to attract clients seeking boutique, high-quality, customizable sequencing solutions, especially in the research segment.